Zilucoplan Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: RA101495

Pipeline

Phase 3: 1Phase 2/3: 1

Top Sponsors

UCB Biopharma SRL1
Miriam Freimer1

Indications

Cancer2
Generalized Myasthenia Gravis1
Generalized Myasthenia Gravis (gMG)1

Chicago, Illinois1 trial

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Mg0014 50168

Phase 2/3

Columbus, Ohio1 trial

Zilucoplan for Severe gMG Exacerbations

The Ohio State University

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.